These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5380215)

  • 1. [Tubazid therapy of cavernous pulmonary tuberculosis in rabbits].
    Bondarev IM; Klebanova AA; Novoselova VP
    Probl Tuberk; 1969; 47(1):77-83. PubMed ID: 5380215
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tubazid treatment of cavernous pulmonary tuberculosis in the dog].
    Bondarev IM; Zhigalina LI; Novoselova VP
    Probl Tuberk; 1968; 46(7):74-9. PubMed ID: 5709506
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effectiveness of the treatment of pulmonary tuberculosis with INAH preparations in different degrees of tubazid inactivation].
    Kagramanov AI; Ezerskiĭ VF; Ezerskaia EN; Kiroshka IZ; Grigorian VG
    Sov Med; 1973 Jul; 36(7):82-4. PubMed ID: 4776714
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cavern morphology and the dynamics of the bacterial population in different variants of an experimental model of cavernous pulmonary tuberculosis].
    Khomenko AG; Uvarova OA; Kozulitsyna TI; Golyshevskaia VI; Lesnaia AA
    Probl Tuberk; 1982 Jan; (1):53-8. PubMed ID: 7058193
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental studies on the pulmonary artery ligation. II. Pulmonary artery ligation and rabbit pulmonary tuberculosis with and without INAH treatment].
    Kato Y
    Sapporo Igaku Zasshi; 1965 Dec; 28(6):484-98. PubMed ID: 5896349
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mechanism of the action of ultrasonics in cavernous pulmonary tuberculosis in rabbits].
    Mexenskaia AIa; Klebanova AA
    Probl Tuberk; 1975; (1):74-6. PubMed ID: 1144373
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ethionamide and tubazid in the therapy of pulmonary tuberculosis].
    Pudoĭ NM; Iampol'skaia SA
    Klin Med (Mosk); 1969 Dec; 47(12):74-9. PubMed ID: 5382417
    [No Abstract]   [Full Text] [Related]  

  • 8. [Inactivation of tubazid and its influence on the effectiveness of antibacterial therapy of patients with pulmonary tuberculosis].
    Sumbatov GA; Ioffe RA; Poliakova SG
    Probl Tuberk; 1965; 43(8):23-8. PubMed ID: 5869065
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of corticotherapy on the residual pulmonary lesions after antitubercular chemotherapy].
    Araszkiewicz W
    Gruzlica; 1969 Mar; 37(3):223-34. PubMed ID: 5814946
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of the efficiency of activity of the liposomal form of isoniazid against different types of mycobacteria in vitro].
    Golyshevskaia VI; Selishcheva AA; Martynova LP; Lepekha LN; Kalashnikova TM; Kornilova ZKh; Erokhin VV; Rozenberg OA
    Probl Tuberk Bolezn Legk; 2006; (8):61-4. PubMed ID: 17002062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathomorphological assessment of the therapeutic effect of mycobacteriophages in tuberculosis].
    Zemskova ZS; Dorozhkova IR
    Probl Tuberk; 1991; (11):63-6. PubMed ID: 1775467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of the tuberculin response of rhesus monkeys by isoniazid therapy.
    Gibson JP; Rohovsky MW; Newberne JW
    Lab Anim Sci; 1971 Feb; 21(1):62-6. PubMed ID: 4322780
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative data on the tolerance of phthivazid, methazid and tubazid in patients with pulmonary tuberculosis].
    Stepanian ES
    Vrach Delo; 1965 Oct; 10():8-10. PubMed ID: 5896073
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmoary tubercular lesions modified by chemotherapy.
    Goyl RK; Arora HL; Sharma ML
    J Indian Med Assoc; 1969 Feb; 52(3):101-3. PubMed ID: 5797826
    [No Abstract]   [Full Text] [Related]  

  • 15. [One-year results of initial therapy of cavernous pulmonary tuberculosis with isoniazid, streptomycin and ethionamide].
    Zajaczkowska J; Krychniak W; Krakówka P; Buraczewska M
    Gruzlica; 1965 Jul; 33(7):565-70. PubMed ID: 5849562
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical significance of the inactivation of tubazid in the endobronchial method of treatment of destructive pulmonary tuberculosis].
    Kanevskaia SS; Rzhavskov IuV
    Probl Tuberk; 1967; 45(10):44-8. PubMed ID: 5617546
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined therapy with isoniazid and ethionamide in ulcero-caseous tuberculosis.
    Cornea P; Nisim F; Nicoulescu F
    Ther Hung; 1966; 14(1):24-9. PubMed ID: 5946507
    [No Abstract]   [Full Text] [Related]  

  • 18. [Preliminary study on isoniazid-epiroprim combination in a tuberculosis murine model].
    N'guessan K; Dosso M; Marchal G; Chavarot P; Romain F; Pescher P; Edy
    Bull Soc Pathol Exot; 2002 Nov; 95(4):265-8. PubMed ID: 12596375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion by isoniazid of hyperacute to chronic pulmonary tuberculosis in mice. II. Histopathology of lungs.
    Mayer E; Salamandra IA
    Am Rev Respir Dis; 1967 Aug; 96(2):220-8. PubMed ID: 4951907
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mechanisms of anti-inflammatory activity of antioxidants in lung tuberculosis].
    Andrzheiuk NI; Kruglova EG; Novosëlova VP
    Probl Tuberk; 1994; (2):49-53. PubMed ID: 8036223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.